Global research trends on anti-PD-1/anti-PD-L1 immunotherapy for triple-negative breast cancer: A scientometric analysis

Global research trends on anti-PD-1/anti-PD-L1 immunotherapy for triple-negative breast cancer: A scientometric analysis

In recent years, anti-PD-1/anti-PD-L1 has been considered to be a valuable therapeutic target and prognostic indicator for triple-negative breast cancer. We analyzed all publications published in the field from their inception until the present day in order to determine the current research status a...

Full description

Bibliographic Details
Main Authors: Jinyao Wu, Yaokun Chen, Lingzhi Chen, Zeqi Ji, Huiting Tian, Daitian Zheng, Qiuping Yang, Yiyuan Liu, Jiehui Cai, Jiehua Zheng, Yexi Chen, Zhiyang Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Oncology
Subjects:
triple-negative breast cancer
PD-L1
PD-1
immunotherapy
scientometrics
VOSviewer
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1002667/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1002667/full

Similar Items